Intellera has acquired PredictBy, a Spanish research and advisory firm specializing in the Life Sciences sector, to enhance its international growth strategy and service offerings.

Information on the Target

Intellera has completed the acquisition of PredictBy, a Spanish research and advisory firm that specializes in the Life Sciences sector, encompassing health, environment, and pharmaceuticals. PredictBy employs data and behavioral science methodologies to assist both companies and institutions in making informed decisions.

This acquisition marks a significant milestone for Intellera, as it represents their first expansion outside of Italy. With the recent establishment of a Brussels office in 2022, acquiring PredictBy furthers the company's strategy for international growth and enhances service offerings in Spain and other European institutions.

Industry Overview in Spain

The Life Sciences sector in Spain has been experiencing robust growth, driven by increasing investments in research and development, as well as the government's commitm

View Source

Similar Deals

Miura Partners Centro Psicosanitario Galiani and Orientak

2025

Other Private Equity Hospitals, Clinics & Primary Care Services Spain
Miura Partners Saesco Medical

2025

Other Private Equity Advanced Medical Equipment & Technology (NEC) Spain
Palex Werfen's Medical Devices and Scientific Instrumentation Distribution businesses

2024

Other Private Equity Medical Equipment, Supplies & Distribution (NEC) Spain
Romano Senior DomusVi

2024

Other Private Equity Residential & Long-Term Care Spain
Agomab Therapeutics NV Origo Biopharma S.L.

2021

Other Private Equity Bio Therapeutic Drugs Spain

Intellera

invested in

PredictBy

in 2024

in a Other Private Equity deal

Deal Parameters
Industry
Country
Seller type

Sign Up to Dealert